Journal
KIDNEY INTERNATIONAL
Volume 79, Issue 3, Pages 265-267Publisher
ELSEVIER SCIENCE INC
DOI: 10.1038/ki.2010.459
Keywords
-
Categories
Ask authors/readers for more resources
The goal of a bundled payment policy for dialysis is to decrease overall expenditures and shift financial risk from the payer to the provider. The primary target for cost reduction is invariably erythropoiesis-stimulating agents (ESAs), because of their large costs and potential for dose sparing. Japan succeeded in reducing ESA doses and maintaining stable hemoglobin levels through modest increases in intravenous iron administration. Dialysis providers in the United States have this and other strategies available. Kidney International (2011) 79, 265-267. doi:10.1038/ki.2010.459
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available